These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1507722)

  • 1. [Experimental and clinical study of intravesical BCG therapy. The role in the prevention of recurrence of superficial bladder tumor].
    Hirano A
    Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1052-61. PubMed ID: 1507722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical bacillus Calmette-Guerin instillation therapy in superficial bladder cancers--clinical study on prognostic factors].
    Shinka T; Hirano A; Uekado Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):425-32. PubMed ID: 2359220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical Bacillus Calmette-Guérin treatment for superficial bladder tumours.
    Shinka T; Hirano A; Uekado Y; Kyoku I; Aoshi H; Ohkawa T
    Br J Urol; 1989 Jun; 63(6):610-5. PubMed ID: 2752253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of prognostic factors of superficial bladder cancer treated with intravesical bacillus Calmette-Guerin.
    Shinka T; Hirano A; Uekado Y; Ohkawa T
    Br J Urol; 1990 Jul; 66(1):35-9. PubMed ID: 2393797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guérin: a long-term follow-up.
    Shinka T; Matsumoto M; Ogura H; Hirano A; Ohkawa T
    Int J Urol; 1997 Mar; 4(2):139-43. PubMed ID: 9179686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence].
    Irie A; Lee KE; Kadowaki K; Sawamura M
    Hinyokika Kiyo; 1994 Oct; 40(10):873-7. PubMed ID: 7992700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer].
    Segawa N; Inamoto T; Nomi H; Ibuki N; Azuma H; Katsuoka Y
    Hinyokika Kiyo; 2009 Apr; 55(4):175-80. PubMed ID: 19462820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study on prophylactic intravesical instillation of bacillus Calmette-Guerin (BCG) and adriamycin for superficial bladder cancers].
    Tachibana M; Jitsukawa S; Iigaya T; Shibayama T; Baba S; Deguchi N; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1459-65. PubMed ID: 2601218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guérin for superficial bladder cancer recurrence.
    Irie A; Uchida T; Yamashita H; Matsumoto K; Satoh T; Koh H; Shimura S; Iwamura M; Baba S
    Int J Urol; 2003 Apr; 10(4):183-9. PubMed ID: 12657096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer.
    Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K
    J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: study on significance of additional maintenance instillations of bacillus Calmette-Guerin].
    Yabusaki N; Komatsu H; Tago K; Yamada Y; Ueno A
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):290-6. PubMed ID: 1904120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer and carcinoma in situ of the bladder. Bladder cancer BCG Study Group].
    Akaza H; Kameyama S; Kakizoe T; Kojima H; Koiso K; Aso Y; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):183-9. PubMed ID: 1556836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer. Prospective randomized study for prophylactic effect].
    Yamamoto T; Hagiwara M; Nakazono M; Yamamoto H
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):997-1001. PubMed ID: 2214478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Fish RG; Mason M
    Cochrane Database Syst Rev; 2000; 2000(4):CD001986. PubMed ID: 11034738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer.
    Baba M; Kageyama S; Yoshida T; Fujiwara R; Kim CJ; Takimoto K; Nagasawa M; Soga H; Nagatani Y; Nishikawa Z; Kawauchi A
    Int J Clin Oncol; 2018 Oct; 23(5):951-956. PubMed ID: 29761307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors.
    Lüftenegger W; Ackermann DK; Futterlieb A; Kraft R; Minder CE; Nadelhaft P; Studer UE
    J Urol; 1996 Feb; 155(2):483-7. PubMed ID: 8558641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
    Melekos MD; Chionis HS; Paranychianakis GS; Dauaher HH
    Cancer; 1993 Sep; 72(5):1749-55. PubMed ID: 8348504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.